
Manitoba First Nations leaders say they want to hear more about reconciliation in federal election
Some First Nations leaders in Manitoba say they're disappointed reconciliation has taken a back seat so far in the federal election campaign.
The issues of Canadian sovereignty, and which party will be most capable of handling U.S. President Donald Trump and the ongoing trade war, have overshadowed other issues that are important to Indigenous communities, says Renee Greyeyes, president and CEO of the Indigenous Chamber of Commerce Manitoba.
"At the federal level we haven't heard a whole lot … especially when it comes to Indigenous businesses or what supports are going to be there" during the campaign, now in its second week, she said in an interview.
Brokenhead Ojibway Nation Chief Gordon Bluesky said he would like to see the prosperity of First Nations mentioned "in the same breath" as the rest of the country's, as parties make pledges to strengthen the economy amid U.S. pressure.
"I'm still waiting for that large announcement, whether it be in our infrastructure, whether it be in … our economic gaps that we have," he told CBC.
"We have all these communities with a lot of these low-hanging fruits and challenges … [which] I really believe that the federal government and the provincial government can really come together on, and to really start to build and create reconciliation."
During a campaign stop in Winnipeg Tuesday, Liberal Leader Mark Carney responded to reporters' questions about his commitments to reconciliation by pointing to actions he took soon after becoming prime minister, including meeting with the leadership of Indigenous organizations and doubling an Indigenous loan guarantee program.
"The process of reconciliation, which is fundamental to our country, fundamentally part of our being … must proceed," he said. "This is a long process, but we've taken those initial steps to move forward."
Conservative Leader Pierre Poilievre said Tuesday his government would establish an Indigenous opportunities corporation, which would offer loan guarantees to Indigenous communities as part of a series of commitments the party says will speed up energy projects and end the sector's dependence on the U.S. market.
"We want to give control to First Nations so that they can make these investments," Poilievre said.
A spokesperson from the federal NDP said in an email the party remains committed to working alongside Indigenous communities as they "empower, uplift and demand justice for their peoples."
Meanwhile, the Assembly of First Nations is calling on all federal parties to commit to upholding rights and advancing nation-to-nation relationships if they form government.
National Chief Cindy Woodhouse Nepinak said in a news release Tuesday that more than $50 billion worth of projects are set to launch on traditional lands over the next decade.
"The potential benefit of these projects is in the trillions of dollars," she said. "They represent a cornerstone of Canada's future economic growth, but they won't advance without First Nations support."
Reconciliation at core of resource development: chief
Derek Nepinak, chief of Minegoziibe Anishinabe — a western Manitoba First Nation formerly known as Pine Creek — said that while reconciliation isn't front and centre in the campaign leading up to the April 28 election, it's at the core of debates surrounding issues like resource development.
"If anyone's going to be developing … Canada's rich mineral wealth, they're going to have to go through Indigenous leadership," Nepinak said in an interview.
"That means negotiation, consultation, accommodations and reconciliation being at the heart of those conversations."
Nepinak said he believes that may indicate a shift in how reconciliation is talked about going into the future.
"It doesn't diminish or take away from the importance of reconciliation by … not having it embedded in a platform," he said.
Brokenhead Ojibway Nation's Bluesky said some Indigenous people may have historically opposed voting because of Canada's colonial roots, but more are starting to believe their voices do matter, he said.
"We can really start to make real changes … if we were to work together," said Bluesky.
WATCH | First Nations leaders want more focus on Indigenous issues in campaign:
First Nations leaders hope for more focus on reconciliation in federal election
11 hours ago
Duration 2:05
Some First Nations leaders in Manitoba say amid all the talk of U.S. President Donald Trump and tariffs, Canada's relationship with Indigenous people has taken a back seat during the federal election campaign.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Japan Forward
an hour ago
- Japan Forward
AI Tool 'KIBIT': A Game Changer in New Drug Development
このページを 日本語 で読む The COVID-19 pandemic reminded the world of the importance of drug discovery. However, modern drug discoveries require massive financial investment. Meanwhile, the use of artificial intelligence for AI drug discovery is gaining attention as a way to control soaring pharmaceutical prices. And a Japanese-made AI tool named 'KIBIT' is about to open up a new stage in this field. President Donald Trump issued executive orders in April and May mandating the reduction of domestic drug prices in the United States. Accompanying White House fact sheets refer to the high cost Americans pay for prescriptions, which is 2.78 times higher than the OECD average. Prescription costs are also 3.47 times higher than in Japan. Trump sees these high costs to consumers as a serious issue. In Japan, a national drug pricing system sets medication prices, enabling access to affordable treatments due to governmental oversight. In contrast, US pharmaceutical companies can set prices freely. This often results in higher charges than in other countries. Following his May 12 executive order, Trump stated that his orders would cut prices by 59% to as much as 90% to align with the levels of other countries. This could potentially result in significant revenue losses for the pharmaceutical industry. In the case of Japan, major pharmaceutical companies such as Takeda Pharmaceutical Company Limited and Astellas Pharma Inc earn over 30% of their revenue from the US. According to his comments, the President could impose additional tariffs on foreign-manufactured drugs if prices are not reduced. In the search for new drugs and treatments (Screenshot, ©FRONTEO Inc) One major reason for rising drug prices is the increasing cost of research and development. The average R&D spending by Japanese pharmaceutical companies rose from ¥30.2 billion JPY ($298.7 million USD) in 1993 to 163.3 billion ($1.13 billion) in 2019 — a 5.4-fold increase over 26 years. US companies saw an even sharper rise, from $841 million (¥121.1 billion) to $7.449 billion (¥1.0725 trillion). That marked an 8.8-fold increase. Moreover, investing in R&D doesn't guarantee success. The probability of developing a successful drug in Japan dropped from 1 in 13,000 two decades ago to 1 in 23,000 recently. Despite the increasing costs, results are scarce. Consequently, the R&D-to-revenue ratio rose from about 10% in 1993 to around 18% in 2019 in both countries. Introducing KIBIT. (Screenshot ©FRONTEO Inc) AI is being eyed as a solution to reduce R&D costs by dramatically cutting time and expenses. Drug development involves four stages: Basic research & target identification Compound optimization Preclinical trials and Clinical trials. Many AI vendors are involved in drug discovery. In particular, they focus on reducing costs in the third (preclinical) and fourth (clinical) stages. However, most companies have yet to tackle the critical first stage — target identification. Introducing KIBIT. (Screenshot, ©FRONTEO Inc) The first enterprise to address this initial stage is the Japanese company FRONTEO. Utilizing its proprietary natural language processing AI engine KIBIT, the company analyzes vast medical and pharmaceutical literature to generate innovative drug ideas that researchers may not have considered. Human thinking is inherently biased. The more experienced a researcher is, the more difficult it becomes to identify novel molecular targets. Stated another way, the bias of experience often blocks new ideas. KIBIT, however, is free from such biases. It identifies new molecular targets that might be effective against specific diseases. To do so, it analyzes vast amounts of academic literature. It can even derive specific hypotheses. Furthermore, KIBIT can identify and suggest highly disease-relevant target molecules that are not explicitly mentioned in the literature. This significantly enhances drug discovery potential. How KIBIT works. (Screenshot, ©FRONTEO Inc) Only a few countries have the capacity to develop new drugs. In 2024, among newly approved pharmaceuticals in Japan, the US, and Europe, the US led with 143 products. Japan followed with just 12, roughly equal to the United Kingdom's 10. According to the statistics "Nationalities of companies creating the top 100 drugs in the world by sales (2022),": United States – 52 United Kingdom – 10 Switzerland – 9 Germany – 8 Denmark – 8 Japan – 7 Most countries, other than the US, struggle to produce blockbuster drugs. In this context, hopes are high for FRONTEO's KIBIT. If it can consistently generate innovative new drugs efficiently, it may help deliver affordable medicines to those in need, without Mr Trump's intervention. FRONTEO's AI drug discovery service, utilizing KIBIT, is already being adopted by several major pharmaceutical companies. Those leveraging KIBIT to create new drugs could become game changers in the industry. This article is contributed by FRONTEO Inc, a supporting member of JAPAN Forward. (Read the report in Japanese.) Author: FRONTEO Inc. このページを 日本語 で読む


Toronto Star
an hour ago
- Toronto Star
Competition Bureau seeking public input on algorithmic pricing
OTTAWA - The Competition Bureau says it's looking for public input as it delves deeper into the rising trend of companies using algorithms to set prices. In a paper released Tuesday, the bureau says more than 60 companies in Canada already use automated systems to help set prices, often in real time, for everything from concert tickets to ridesharing to hotel rooms. The paper says that algorithmic pricing could improve competition by helping businesses innovate and be more efficient, but also risks making it easier for companies to co-ordinate their prices and could make it harder for new companies to enter the market. ARTICLE CONTINUES BELOW It says algorithmic pricing could become an issue under the Competition Act if multiple companies rely on the same model to set pricing, creating a form of collusion on pricing even without explicit collaboration. The bureau says the systems could also be used for predatory pricing if a company uses them to specifically target specific customers of rivals, rather than lowering prices overall. The Competition Bureau confirmed in February that it was also investigating the possible use of AI-driven algorithmic pricing in Canadian real estate rental markets. This report by The Canadian Press was first published June 10, 2025.


Toronto Star
an hour ago
- Toronto Star
Los Angeles imposes downtown curfew as protests against Trump's immigration crackdown continue
LOS ANGELES (AP) — Los Angeles leaders imposed a downtown curfew through Wednesday morning to deal with protests against President Donald Trump's immigration crackdown, while the governor accused him of drawing a 'military dragnet' across the nation's second-largest city with his escalating use of the National Guard. Democratic Gov. Gavin Newsom asked a court to put an emergency stop to the military helping federal immigration agents, with some guardsmen now standing in protection around agents as they carried out arrests. He said it would only heighten tensions and promote civil unrest. The judge chose not to rule immediately, giving the administration several days to continue those activities before a hearing Thursday.